![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2007 M. Jäger et al. Significance of Nano- and Microtopography for Cell-Surface Interactions in Orthopaedic Implants 1Department of Orthopaedics, Heinrich-Heine University Medical School, Moorenstrasse 5, 40225 Duesseldorf , Germany 2Institute of Anatomy II, Heinrich-Heine University Medical School, Universitätsstrasse 1, 40225 Duesseldorf, Germany *M. Jäger: Email: drjaegermarcus/at/yahoo.de Recommended by Hicham Fenniri Received March 18, 2007; Accepted August 5, 2007. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Cell-surface interactions play a crucial role for biomaterial application in orthopaedics.
It is evident that not only the chemical composition of solid substances influence cellular adherence,
migration, proliferation and differentiation but also the surface topography of a biomaterial.
The progressive application of nanostructured surfaces in medicine has gained increasing interest
to improve the cytocompatibility and osteointegration of orthopaedic implants. Therefore, the
understanding of cell-surface interactions is of major interest for these substances. In this review,
we elucidate the principle mechanisms of nano- and microscale cell-surface interactions in vitro for
different cell types onto typical orthopaedic biomaterials such as titanium (Ti),
cobalt-chrome-molybdenum (CoCrMo) alloys, stainless steel (SS), as well as synthetic polymers
(UHMWPE, XLPE, PEEK, PLLA). In addition, effects of nano- and microscaled particles and their
significance in orthopaedics were reviewed. The significance for the cytocompatibility
of nanobiomaterials is discussed critically. 1. INTRODUCTION Nanobiomaterials are characterized by constituent
particles and/or surface features less than 100 nm
in at least one dimension
[1].
Starting with photolithography and dry etching in the
1980's to high-resolution electron beam lithography and other technologies
in the 1990's, nanotechnology allows for making surface structures for
cell engineering and has led to an increasing application in healthcare over the last decades.Nanolayers are used to enhance the
surface biocompatibility of polymeric drug delivery systems,
control the release of substances such as antibiotics or growth factors
[2], act as gene-delivery
vehicles, or serve as robust light emitters for
cellular labeling and tracking
[semiconductor nanocrystals, quantum dots (QDs)]
[3].
Nanotechnology is also applied to modify and improve the surface
structure in orthopaedic implants to promote their
osseous integration. However, there are also side effects of nano- and
microparticles in vivo.
Micro- and nanoparticles released by friction of
articulating partners from artificial joints are a major
reason for aseptic
implant loosening in orthopaedic surgery and may lead to severe
peri-implant
osteolysis (particle disease)
[4]. In addition,
nanoparticles can induce or promote allergic or inflammatory
reactions or
influence hemolysis and blood coagulation
[5–7]. Although the cytocompatibility of a biomaterial
is strongly influenced
by its chemical composition, surface topography plays a
crucial role for cell-surface
interactions [8]. Material surface
properties have been studied intensively, but
still lack from reliable data about cytocompatibility. Especially, the
superordinate principles of cellular responses to
surfaces with a defined
topography are not well known and poorly understood.
Because many variables
influence cellular interactions to surface structures,
it is difficult to draw
conclusions and formulate general principles for
nano- and microstructured
surfaces. This review summarizes recent data of effects by nano- and
microstructured biomaterials and particles in vitro designed for
orthopaedic application to get a solid
framework outlining the critical interactions that govern the
cytocompatibility.
Because biomaterials in orthopaedics are predominantly
applied on bone, this review is focussed on
the interactions of osteoblasts
and bone-marrow-derived
cells with structured biomaterials. 2. BONE CELLS Osteoblasts and osteoclasts are mainly
responsible for the osteointegration of
nanostructured biomaterials in orthopaedics.
Osteoblasts derive from
mesenchymal progenitor cells which are localized mainly
in the bone marrow and
periosteum. They are characterized by cuboidal
and flat morphology (diameter about
20 μm), present a large
amount of rough endoplasmatic reticlum and a large Golgi apparatus,
and are potent to produce osteoid, a collagen I rich matrix
[9].
In addition, these mononuclear cells are also responsible
for osteoid calcification (hydroxyapatite). Typical marker proteins for
osteoblasts are Cbfa1/Runx2, osteocalcin, osteopontin, osteonectin, bone
sialoprotein (BSP), osteoprotegerin
(OPG), collagen I, and alkaline phosphates
(ALP). Figure 1
When trapped into the mineralized bone, osteoblasts differentiate
into osteocytes. Osteocytes act in a paracrine and mechanosensory manner, and
can activate osetoblasts and osteoclasts.
The latter cell type derived from the
hematopoietic line, has multiple nuclei and is
responsible for bone resorption.
Its ruffled border is flanked
by a sealing zone which facilitates local acidification
and removal of bony
matrix such as Ca2+, H3PO4, and
H2CO3
by endocytosis. Osteoclasts express
high levels of tartrate-resistant acid phosphatase
(TRAP) and cathepsin K. The
interaction between osteoblasts and osteoclasts is complex. During differentiation, the ostoblast progenitors express receptor
activator of nuclear
factor κβ ligand (RANKL) and macrophage colony-stimulating factor
(M-CSF) which are strong stimuli for osteoclastogenesis. In contrast,
osteoprotegerin (OPG) is a potent inhibitor
of osteoclasts. Moreover, the
interactions between osteoblasts and osteoclasts in vivo are regulated
by several hormones and cytokines, including parathyroid hormone (PTH),
calcitonin, and IL-6. 3. CYTOCOMPATIBILITY OF MICRO- AND
NANOSTRUCTURED SURFACES 3.1. Principles and problems It is generally accepted that the
three-dimensional surface topography
(size, shape, surface texture) is one of
the most important parameters that influence cellular reactions
[2, 11–19].
Although many studies have investigated
cellular reaction to different surface pattern,
the significance of macro
structure studies on bone cell behavior is
questionable since in vivo adhesion
structures (e.g., cell membranes,
basement membranes) are comprised of much
smaller nanometer scale features [20, 21]. The immature bone is characterized by an average
inorganic grain size of
10–50 nm whereas mature bone has an average
inorganic grain size of 20–50 nm
(2–5 nm in diameter)
[22].
Considering these parameters, modern
implants for bone application have been
designed with a smooth surface at the
nanometer level. It was surprising that
some of these have induced the formation of peri-implant
fibrous tissue and
implant loosening in vivo, while other implants with a higher
degree of roughness showed significant better osteoconductive properties
[23–25].There are various methods to modify the degree of
roughness as well as surface energy
and topography in orthopaedic implants.
Typically applied techniques to enhance
the degree of roughness and promote
the osteointegrative properties of
biometals (e.g., Ti, CoCrMo, SS) are chemical
etching or anodization and
also sand-blasting, sputter-coating, and machine-tooling. The lack of knowledge in cellular reaction to
nanostructered biomaterials is based
to a great extent on
the difficulty in varying surface chemistry and
topography independently. Moreover,
the use of different cell lineages and culture
conditions makes it difficult to
compare results from different investigators
[26–31]
(Table 1).
There is also a lack of consensus concerning the
proper representation of implant surface topography
[32].
One major misunderstanding is the practice of defining a
surface by its manufacturing process instead of concisely defining the
topographic measurements [17, 33].
Considering these limitations for interpretation, the
following review gives an overview of cellular
reactions to surface structures
of different orthopaedic biomaterials.
The first step after exposure of any biomaterial
to a biological environment results in the rapid
adsorption of proteins to its
surface [34].
The composition, type, amount, and
conformation of adsorbed proteins regulate the
secondary phenomena such as
cellular adherence and protein exchange
[35–37]
and also following cellular reactions such as migration,
proliferation, and differentiation.
The potency for biomaterials to adsorb
proteins is influenced by its physiochemical
characteristics such as surface energy or hydrophobicity,
and is also dependent on
the local environment (
For inorganic nanocrystals and microstructured
surfaces there are at least two approaches to change
their hydrophobic surfaces:
a ligand exchange reaction can replace the original
hydrophobic surface with
bifunctional coupling molecules or an inorganic
coating such as silica (1) or
an encapsulation of nanocrystals in an
amphiphile organic coating (2). The first phase of protein adsorption onto a
biomaterial's surface is characterized
by the attachment of small rapidly diffusing
proteins, followed by a progressive replacement by larger
proteins with a high
affinity to the substrate. Here, especially proteins
with Arg-Gly-Asp (RGD)
containing sequences such as fibronectin or
vitronectin act as cell receptors
and have chemotactic or adhesive properties to bone cells.
In addition, these RGD-peptides
also have a strong effect on matrix maturation
and biomineralization [46–48]. After conditioning of a naked biomaterial by protein adsorption, cells attach rapidly
on the protein-coated surface [49].
Besides the influence of proteins, the
cellular attachement to a nanostructed surface
is also influenced by its physiochemical
properties, especially by the outer functional groups
[30, 50, 51]. Schweikl et al. [52]
showed on self-assembly monolayers that the
osteoblast proliferation on hydrocarbon
chains, terminated by −CH3,
was as high as on amino groups
(−NH2)
and hydrophilic oxidized surfaces, but significantly lower
on fluorocarbon
(−CF3)
groups. Möller et al
. [53]
showed that
3-aminopropyl triethoxysilane (APTS)
presents amine functional groups which allow for
grafting RGD tripeptides and
that the RGD-APTS hybrid promotes cell adhesion,
spreading, and cytoskeletal
organization. Here, the zetal potential (differences in potentials
between the surface of a tightly
bounded layer and a diffuse layer)
and the interfacial tension (wettability) of
a surface is crucial [54, 55]. It was demonstrated for cpTi surfaces that the contact angle (CA),
parameter for
wettability, increases linearly with the average roughness when
the angles were
higher than 45° , but decreases linearly with roughness
when the angle was less
than 45° [56].
Recent data examining osteoblast
response to controlled surface chemistries indicate that
hydrophilic surfaces
(high number of polar components) improve cell attachment
and matrix synthesis and also the osteogenic
potency compared to hydrophobic
surfaces [57–59].
Stock et al. [60]
compared Ti alloys and CoCr alloys towards protein
absorptive properties and cell attachment with an
osteoblast precursor cell
line. They found no significant
differences between Ti alloys and CoCr,
but significantly greater cell adhesion
rates for the Ti implants and concluded that cell
adhesion is a result of
higher hydrophilicity of Ti alloys. In
contrast, other data showed that a low degree
of wettability promotes protein
adhesion and also cellular attachment to a biomaterial
[61],
and Möller et al. [55]
found no direct correlation between the
wettability of the material surface and the osteoblast attachment and
proliferation rate. Also Qu et al. [62]
found no significant differences of cell attachement
on various titanium surfaces with different degrees of wettabilities
(hydrophobic acid-etched, coarse-blasted large
grit acid-etched, hydrophilic modified
acid-etched, and modified coarse-blasted large grit,
acid-etched
) on MG68 cells. Heating (oxygen/atm) or peroxide treatment of biometals
result in a thicker oxide layer
and a more hydrophilic surface. Kern et al.
[63] showed that
heat-treated titanium
surfaces changed the wettability (more hydrophilic)
but does not significantly
affect the fibronectin and albumin adsorption as well as
the initial osteoblast
precursor cell attachment in vitro.
Based on data from their in vitro experiments, MacDonald et al.
[64]
emphasized that the rate
of protein correlates more with changes in chemical
composition than
with changes in wettability in metal surfaces. They showed that
a preheating of Ti6Al4V specimen does not only lead to a
thicker oxide layer but also results in
an enrichment of V and Al within
the surface oxide. In contrast,
post-treatment with butanol after preheating
reduces the content of V, but not in Al,
and significantly increases the rate
of fibronectin adsorption up to 20–40%
[64]. Compared to the cellular attachment phase, the following adhesion
phase lasts longer and
involves various proteins and molecules
(Figure 2 It has been shown that nanotube or nanoparticle surfaces
created by anodization have
promoted osteoblast adhesion up to three times
compared to unanodized Ti [66].
These results were confirmed by the group of Webster
[67]
and other investigators [68–71]
who demonstrated that the initial
attachment of osteoblasts onto the surface of biometals such as cpTi,
Ti6Al4V, and CoCrMo is enhanced by submicron to nanometer
consistent particles compared
to metals composed of respective micron particles.
One possible explanation of
this phenomenon is the higher amount of particle binding sites for
osteoblast adhesion at the surfaces of nanophase metals
compared to micron particle size
metals. The theory of enhanced protein and cell binding capacities
by larger
surface areas/roughness degrees was also confirmed for porous
HA materials [72]. Another example of the significance of surface structures
for protein binding and
osteoblast attachment is the helical rosette nanotubes
(HRN) which can build
self-assembly surface structures. It was demonstrated that
a significant change
of HRN coverage by heating correlated with the protein-binding
and osteoblast
adhesion potency in titanium surfaces [73,
74]. It is evident that not only the surface topography
influences protein deposition and
cell adherence but also proteins and cells modify the surface
properties of a
defined surface. Based on a surface analysis of the different
biometal specimen
before and after cell cultivation, we showed previously
[57]
that a cell attachment and/or protein
precipitation increase the roughness in polished biomaterials
(steel, Ti6Al4V,
and CoCr). For porous coated CoCr surfaces, we found only slight and no
relevant changes in roughness whereas cell cultivation onto
sandblasted Ti6Al4V
lead to a strong decrease in specimen roughness.
Both, the increase in roughness after
cell culturing in the different biometals
and the decrease in roughness of sandblasted Ti6Al4V could be
explained by the
dense cellular growth and accumulation of debris in depth of
the structured surfaces
and/or protein deposition as shown by other investigators
[75, 76]. In addition, not only the amount but also the type of
protein adsorption by a
surface is crucial for cellular adherence and following reactions such as
migration and differentiation. As an example, Ti surfaces (Ra:
0.37–0.01 μm) adsorp
fibronectin in higher concentrations
compared to albumin, and fibronectin-coated Ti surface promoted
more osteoblast attachments
in comparison to albumin-coated Ti surfaces
[77].
These results correspond to the data of other authors
who showed excellent osteoconductive properties after
fibronectin adsorption
onto a biomaterials' surface [78–80].Based on IRM and TEM analysis, the closest distance
of cells to a surface (glass) was
found to be approximately 10 nm [81,
82]. Historically, results from chicken
fibroblasts have lead to a classification of three different types of
separation.(1) Focal contacts (FC): approximately
10–15 nm separation from the substrate under the
peripheral regions of the leading lamellae
(appearing black in TEM). FC act as
an interface between intra and extracellular components and occur linearly
beneath the associated cytoplasmic stress fibres
[83,
84].
They are tenacious adhesion sites that
remain attached to the substratum even when cells are forcibly detached,
indicating their function as anchorage
structures [85].(2) Close contacts: corresponding to approximately
30 nm separation (broader grey areas
in TEM).(3) Greater separation: corresponding to approximately
100–140 nm (white
regions in TEM).It is evident that not only FC appear soon after cellular attachment but also that (β-catenin-positive) adherence
junctions occur within 1–4 hours
for grooved Ti-based substrates [20].
These observations underline the high
significance of an early intercellular communication soon
after adherence to a
surface. The mechanisms of initial cellular adherence to a surface are
different from long-term adherence as shown by a lack of statistical
correlation between short-term adhesion (strength of cell attachment
and early
adhesion) and long-term adhesion (strength of cell-matrix interface)
forces [14, 15, 86].
Based on a progressive
trypsine-detachment method, Bigerelle et al.
[86]
showed that the cultivation time has an
influence on the long-term adhesion in biometal surfaces according to
For polylactides (PLLA), it was shown on OCT-1 osteoblast-like
cells that cell
adhesion but not the proliferation could be enhanced by nanoscale
and microscale
roughness compared to smooth surfaces [87]. In addition,
there is evidence that FC
show a dynamic behavior which allows for cellular migration and motility.
Linear PLLA fibres with length scales of 0.5–2 μm,
constructed by electrospinning, have shown cellular contact
guidance and enhanced
osteoblastic differentiation. Here, cell morphology revealed that cells
grown on fibres had smaller projected areas than those on planar
surfaces [88]. These results were
confirmed by other authors [89–92].
Also other polymers such as PLGA have been shown to
be effective in enhancing osteoblast differentiation in vitro
[93].Diener et al. [94] demonstrated
on MG-63 osteoblastic cells
that FC adhesion was smaller on Ti and SS than on collagen-coated glass
coverslips and that all FC showed a mobility of focal adhesions. However,
Anselme et al. [13] found higher
adhesions on Ti6Al4V
substrates than on noncollagen-covered glass samples,
and emphasized that substrates
with various surface compositions
but with the same surface topography did not
induce significant differences of adhesion. Based on the knowledge of protein adsorption and its effects
on cellular attachment and adherence, a selective surface coating
of nanostructured
surfaces with RGD or collagen proteins offer a promising solution
to improve
the number of osteoblasts adhered on artificial surfaces
[53, 95–102]. Imprinting
surfaces technology with deposition of specific
protein-recognition sites can
help to promote osteoblastic growth
and differentiation [103–106]. Protein-recognition
can be based on a protein-ligand binding and/or electron donor-acceptor
interactions or other types of binding forces. One example is the binding
of different
integrin subunits to fibronectin. Integrin
α5β1 and α5
vβ3 subunits competitively
bind to RGD-sites of fibronectin [107,
108]. Dependent on the
surface topography and
chemistry of the
biomaterial, fibronectin
undergoes changes in structure including
modulation in functional activity and
shift in integrin binding capacity. Based on the data of self-assembled monolayers,
it was shown that integrin subunits
show selective binding capacities to different
terminal groups. Integrin α5β1 shows a
strong affinity to −OH and
−NH2 surfaces, whereas
α5β1 and
α5vβ3 bind also to −COOH but show poor binding capacities
on −CH3
surfaces [109–113]. 3.2. Cellular migration and proliferation Cell migration and proliferation is the attachment
following phase between the cell
and the material surface. It is evident for designing
nanostructured implants
that cells use the nanotopography of a substrate for
orientation and migration [117–119]. Although
it is known that bone cells
align along defined substrate morphologies (contact
guidance), the detailed relation between ordered
nanotopography and cell
behavior remains unknown in detail [120].
For the first time, in 1964 it was shown
that convex surfaces enhance cellular overlap, while
grooves minimize cellular
overlap [82]. As pre-requisite to reach a defined cell colonization during
directed tissue formation, structured nanophase surfaces
lead to a predictable
osteoblast orientation and migration on these surfaces
[17, 121, 122].
Interaction between the ECM and associated
changes in the
orientation of the cytoskeleton are crucial for cell
metabolism of cells and
morphology due to actin-myosin tension structures
[123]. Anisotropic topographies (e.g.,
topographical grooves, chemically patterned stripes,
or curved surfaces of a
fibre) are potent to exert morphological
as well as physiochemical
features on cells at the same time, indicative for the
complex environmental
influence on cells. Focal contacts are important structures for cellular
adherence onto a surface but may
also delay migration and mobility of the cells.
It was shown that bone-derived cells (MG63 cells) respond to
a nanoscale roughness by a higher cell thickness and a
delayed appearance of
focal contacts [20].
Especially, nanoporous
Ti-oxide surfaces promote cellular
spreading and induce numerous filopods and osteoblastic differentiation
[124,
125]. On electrochemically
microstructured hexagonal
pattern, MG63-cells go inside
30–100 μm but not in 10 μm
cavities [20]. Most authors report a
parallel orientation of cells cultured on
polished (smooth) surfaces [57, 114, 126]
(Figure 4
Another method to not only enhance cellular adherence but also to
promote osteoblastic differentiation and
biomineralization of biometals is a surface anodization,
for example, by β-glycerophosphate sodium and calcium
acetate [66–71]. Cellular adhesion via FC may strengthen the linkage
between cell and ECM and
also impair the ability to dynamically remodelling
the ECM and influence the
migration rate [94]. For
collagen-coated coverslips, focal adhesion of MG-63
osteoblastic cells moved
with a speed of 60 nm/min, whereas the speed was
reduced in Ti and more in SS
surfaces [94]. Another study
on Nb2O5-coated
polished cpTi samples showed that MC3T3-E1-osteoblast
migration was fastest on
smooth surfaces (Ra = 7 nm), whereas adhesion strength,
spreading area, and
collagen-I synthesis were promoted by intermediate
roughness (Ra = 15 nm). However,
it was surprising that higher degrees of roughness
(Ra = 40 nm) were rather
peaked and reduced the speed of adhesion process in the
same study [127].Besides the surface properties of a biomaterial,
the cellular migration rate is
dependent on the cell type and its differentiation stage.
A higher migration
rate is associated with a lower level of osteoblast
differentiation. Cells with
a low motility are characterized by a strong formation of FC
while motile cells
form less adhesive structures. It was found that mature
osteoblasts spread out
and form a greater number of FC when settled on smoother surfaces
[28]. Although
cellular spreading is higher on
smoother surfaces, some data indicate that the
ALP-expression is higher for
rough isotropic surfaces (electro-erosion, acid-etching,
sandblasted) compared
to smoother substrates (machine tooling, polishing)
[11]. Considering recent publications, there
is no or only week statistical significance that there
is a difference between
the initial number of adherent cells and following proliferation of cells
cultured onto a biometal or ceramic nano-/microscale surface
in vitro [50]. However,
some authors emphasize that
the influence of functional chemical groups for cellular migration and
proliferation are stronger than general surface
properties such as wettability [51].
Especially a TiO2-layer
seems to promote
cellular growth and proliferation on nanostructured
biometals [128, 129]. 3.3. Cellular differentiation, gene expression,
and protein synthesis Recent studies investigating the response of adherent
cells to nanography surfaces
indicate that different cell phenotypes have different
levels of sensitivities [117, 135–137]. Here,
osteoblasts react to features as
low as to the 10 nm dimensions, which is comparable in size to a single
collagen fibre [138]. Moreover, the qualitative and quantitative kinetics
in gene and protein expression is
strongly influenced by topography and physiochemistry
of a defined surface. Microporous
HA surfaces seem to promote a high number of FC and
increased levels of ALP but
short actin stress fibres compared to nonmicroporous HA surfaces
[72, 139].
There is also evidence that Ti and HA
surfaces can activate early intracellular signalling
pathways as shown by
expression of relevant molecules such as
α- and β1-integrin, FAK, ERK followed
by c-jun and c-fos genes for proliferation and ALP for differentiation
[139, 140].
However, Hallgren et al. [141]
found no significant histomorphometric
and biomechanical differences between nanopatterned and control implants.
Hamilton et al. [142]
showed that microfabricated
discontinuous-edge surfaces (DES),
repeated open square boxes with a depth of
10 μm, alter osteoblast adherence and migration
but enhance cell multilayering,
matrix deposition and mineralization when compared to smooth controls.In contrast to our data [57],
Anselme et al. [13] found
higher proliferation
rates on SS compared to Ti6Al4V. However, Bigerelle et al.
[14] demonstrated that neither
material composition nor surface roughness amplitude influence cell
proliferation, whereas they found a very significant influence
on manufacturing
process and surface topography for long-term adherence
and proliferation in vitro. Our in vitro results [57] confirm the
well known osteogenic in
vivo properties of Ti implants, which may be based on
surface factors observed
on its outer TiO2-layer
[143–146].
Müller et al. [147]
demonstrated the ability of osteoblasts
to grow into an open-porous Ti implant (metal foam) and Li et al.
[148]
also demonstrated that MC3T3-E1 cells
attach to and are able to divide well in the inner surface of
a highly porous
trabecular Ti6Al4V implant. Some in vitro studies demonstrated an
enhanced total protein and collagen production,
as well as increased ALP
activity of osteoblasts cultured on nanoparticulate
metals (cpTi, Ti6Al4V, and
CoCrMo) indicating advantages for nanostructured surfaces
for osteointegration [1, 149, 150]. Based on the
data of Redey et al. [58],
it can be concluded that the low
attachment and collagen production rates are related to a low
wettability of a
nanosurface. Nanotextured surfaces of Ti surfaces
prepared by chemical etching
have upregulated the expression of BSP and
OP [66].
As demonstrated by Qu et al. [62],
the expression of the bone-associated
genes such as ALP, OC, type-I-collagen, osteoprotegerin, and
glyceraldehyde-3-phosphate-dehydrogenase is promoted
by modSLA Ti surfaces.
Some data also suggest that fluoride-modified
Ti surfaces can stimulate
osteoblastic differentiation compared to
unmodified titanium surfaces [151,
152]. Ward et al. [1]
showed in their in vitro experiments that nanophase biometals induce
significantly greater calcium and phosphorus
deposition by osteoblasts and also allow for
calcium and phosphorous precipitation from
culture media without osteoblasts in
contrast to microphase Ti6Al4V and CoCrMo.
Furthermore, the authors found
advantages in mineral precipitation without osteoblast for
TiAl4V but no differences
in dependency to the type of Ti (wrought, microphase,
or nanophase). It was
evident that the increased calcium and phosphorus
mineral content correlated to
greater amounts of underlying aluminium content on
Ti6Al4V surfaces. Although some data indicate
that nanostructured Ti alloys promote non-cell-mediated Ca/PO4-mineral
deposition from culture media compared to CoCrMo substrates,
the greatest cell-dependend calcium and
phosphorus mineral deposition occurred
on nanophase CoCrMo [1]. It is evident that micropattern collagen films or
scaffolds promote not
only cellular adhesion but also allow for
an osteoblastic differentiation and
biocalcification in vitro [153–155].
For HA- and DCPP-coated, Ti
surfaces the Ca/P ratio influence the biomineralization
rate in vitro [156]. Besides the osteoblast-promoting effects
of defined substrates and
surface topographies, some data also allocate
an inflammatory response induced
by nano- or microstructured biomaterials.
It was shown in many studies that
cell-biomaterial interactions can activate macrophages
which results in the synthesis of proinflammatory
agents such as TNFα, IFNγ, IL-1 and -6,
RANKL and NO [157–159]. Some data have
shown proinflammatory effects of different
biomaterials which increase with the
degree of surface roughness.
Here, macrophage inflammatory protein-1, TNFα,
monocyte chemoattractant protein-1, and
members of the interleukine and leukotriene family
play a crucial role in
biometal-induced inflammations
[160–164]. Most studies report about an
enhanced expression of pro-inflammatory
cytokines and chemokines by cells
attached to rougher surfaces [164]. Some data also
indicate that anionic and neutral hydrophilic surfaces
increase macrophage-monocyte apoptosis and reduce macrophage
fusion to modulate
inflammatory responses to implanted materials
[165]. However, adverse cellular effects seen with
metallic implants may
also be attributed to corrosion products or to
the separation of metal ions
(Fe, Cr, Ni) which may have a major impact on cellular survival and
differentiation [166–168].
Those studies which suggest that a cell-mediated metal ion
release by biometals that
did not affect
the cell viability or proliferation are
characterized by short cultivation periods or
other conditions which limit the
reliability of data [169–171]. 3.4. Cytocompatibility of micro- and nanoscaled particles In contrast to the great opportunity enhancing
biocompatibility and osteogenic potency of surfaces applied on bone by
nanotechnology, micro- and nanoscaled particles released by friction of
artificial joints can induce severe
inflammation and may lead to osteolysis and
implant failure [174,
175]
(Figure 5
There is a wide
range in particles size and morphology produced by
simulators for artificial
joints. Particles released from metal-metal (CrCoMo alloys) are
predominantly chromium oxide particles or CoCrMo with
varying ratios of Co and Cr. They show a round to oval morphology
and also a substantial number of needle-shaped
particles were found during the first circles.
O'Connor et al. [176] emphasize the
importance of particle size
as a critical factor in osteoblasts proliferation
and viability in vitro. They showed that 1.5–4 μm
Ti particles have the greatest effect. Some data indicate
that in contrast to Ti-surfaces
nano- and mircoparticles induce an
inflammatory response although titanium is
one of the biometals with the highest degree of
cytocompatibility. As shown by Miyanishi et al.
[177],
the release of VEGF may play a crucial role in the
pathogenesis of Ti-induced osteolysis. Some data indicate that
phagocytosis of Ti particles is not a precondition for
an inflammatory response
such as a release of TNFα or IL-6 in
cultured macrophages [178].
It is evident that a binding of the macrophage CD11b/CD18 (macrophage
Mac-1 receptors/receptor of complement CR3bi,
can also bind to ICAM-1 and
ICAM-2) by integrin-specific antibodies
also increased the release of TNFα and IL-6 in macrophages.
This finding also suggests
that the complement system plays a role in the pathogenesis
of particle-induced
inflammation, too. Especially, UHMWPE particles with
a size range of
0.1–1.0 μm have been shown to be most reactive for
macrophage activation and cytokine
secretion in bone marrow cells [179,
180].However, not only the particle size but also the particle volume
(number) is a critical factor for particle-mediated
release of cytokines by
macrophages. Green et al. [181]
demonstrated for PE
that the cell-particle ratios of 1 : 100
(size 0.49–7.2 μm) and 1 : 10
(size: 0.49–4.2 μm) induced
significant stronger release
of TNFα and IL-1β in macrophages.
The authors conclude that especially
particles in the phagocytosable size range of
0.3–10 μm appear to be the most
biologically active ones.The latter statement was also confirmed for silicon carbide (SiC)
particles and biometals such as cpTi,
Ti6Al4V and UHMWPE [184, 185]. Granchi et al. [192]
investigated the in vitro
effects of Al2O3
and UHMWPE particles in an
osteoblast-osteoclast co-culture system.
Both particles did not affect either
cell viability or TNF and GM-CSF release,
whereas IL6 release was dependent on
the particle concentration. UHMWPE particles
increased the release of RANKL
from osteoblasts and induced large amounts
of multinucleated TRAP-positive
giant cells in an osteoblast-osteoclast
co-culture system. In contrast,
Al2O3 wear debris was less active. Also,
carbon-based particles with low wear
factors such as P25-CVD showed a high degree
of cytocompatibility in vitro. Howling et al.
[191] demonstrated
on fibroblasts and monocytes that P25-CVD
particles <100 nm were significantly less cytotoxic
to both cell types than
CoCr metal wear particles.
While the classical water-suspendable
nano−C60 nanocrystal is apparently
cytotoxic to various cell lines, the closely related
fully hydroxylated,
C60(OH)24
, is nontoxic,
thus producing no cellular
response [197]. Also,
functionalized single-walled carbon nanotubes are nontoxic
to cells in culture [198–200].There is evidence that not only particle
size and chemical content but also the concentration strongly influence
cellular reactions in vitro. Wilke
et al. [189]
showed a positive correlation between the
release of proinflammatory cytokines
(IL-6, -1β, and TNFα) and amounts of
Ti6Al4V-particles
(109,
108, 107,
and 106 particles/ml)
by human bone marrow cells over 2 weeks. Some in vitro data also indicate that Ti particles induce a stronger
fibroblastic differentiation signal than UHMWPE
in monocytes and other cells [182–184]. Warashina et al. [201]
showed that particles
of high-density polyethylene
(HDP) and Ti6Al4V induced significantly more
proinflammatory mediators (IL-1β,
IL-6, TNFα) and bone resorption compared to
Al2O3
and ZrO2 in vivo.
Based on these data,
it can be assumed that ceramics show a high
degree of cytocompatibiltiy. For HA especially, particles with a size
<53 μm inhibit cellular proliferation,
especially in osteoblasts and lead
to a decrease in TGFβ1 and a significant increase in PGE2 and LDH
concentration, but did not influence the TNFα
or ALP titer in vitro [186].
It could be concluded that larger HA particles may
be compatible with bone cells while smaller-sized
HA particles can both activate
the osteoclasts and decrease the cell
population of the osteoblasts in vitro.3.5. Summary and conclusions Numerous variables influence the biocompatibility and osteogenic
potency of nanostructured biomaterials in
vitro and in vivo. Besides the locotypical
environment in vivo or in vitro, the surface
structure and the composition of a
biomaterial affects cellular attachment,
adherence, proliferation and migration,
and also
differentiation and survival of defined cell types.
Here, information about typical
parameters such as chemical composition,
surface structure (topography, geometry,
roughness, particle size), surface energy,
hydrophobicity, and the degree of
solubility in aqueous solutions of a biomaterial
will help to value and grade a
defined implant concerning its osteblast promoting potency. Considering recent publications, we could assume some general
principles of cytocompatiblity and cell-surface
interactions in nano- and
microstructured surfaces. (1) Wettability of a nanosurface influences significantly
protein adsorption, which is a prerequisite
of cellular adherence in serum containing
solutions. (2) Nanostructured surfaces enhance the surface area of
biomaterials and promote cellular adherence. (3) The chemical outer functional
groups of a nanosurface significantly influence cellular
migration, proliferation, and differentiation but direct
correlations between
distinct parameters and cell functions are not entirely cleared. (4) The formation of FC underly a
dynamic process and influence the motility and migration of cells. (5) A higher degree of differentiation
is corresponding to a decreased cellular motility. (6) Phagocytable particles with a size
<10 μm induce the strongest
cellular response with regard to releasing
inflammatory cytokines.(7) Although Ti has a high degree of
cytocompatibility in vitro, phagocytable
Ti particles can induce a fibroblastic
differentiation. lIST OF ABBREVIATIONS
References 1. Ward BC, Webster TJ. The effect of nanotopography on calcium and phosphorus deposition on metallic materials in vitro. Biomaterials. 2006;27(16):3064–3074. [PubMed] 2. Lai C-Y, Trewyn BG, Jeftinija DM, et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle
caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. Journal of the American Chemical Society. 2003;125(15):4451–4459. [PubMed] 3. Alivisatos AP, Gu W, Larabell C. Quantum dots as cellular probes. Annual Review of Biomedical Engineering. 2005;7:55–76. 4. Gul RM, McGarry FJ, Bragdon CR, Muratoglu OK, Harris WH. Effect of consolidation on adhesive and abrasive wear of ultra high molecular weight polyethylene. Biomaterials. 2003;24(19):3193–3199. [PubMed] 5. Di Iorio D, Traini T, Degidi M, Caputi S, Neugebauer J, Piattelli A. Quantitative evaluation of the fibrin clot extension on diffferent implant surfaces: an in vitro study. Journal of Biomedical Materials Research Part B. 2005;74(1):636–642. 6. Inoue K-I, Takano H, Yanagisawa R, et al. Effects of nano particles on antigen-related airway inflammation in mice. Respiratory Research. 2005;6:106. [PubMed] 7. Kim D, El-Shall H, Dennis D, Morey T. Interaction of PLGA nanoparticles with human blood constituents. Colloids and Surfaces B. 2005;40(2):83–91. 8. Meredith DO, Eschbach L, Riehle MO, Curtis ASG, Richards RG. Microtopography of metal surfaces influence fibroblast growth by modifying cell shape, cytoskeleton, and adhesion. Journal of Orthopaedic Research. 2007 9. Schmidt C, Kaspar D, Sarkar MR, Claes LE, Ignatius AA. A scanning electron microscopy study of human osteoblast morphology on five orthopedic metals. Journal of Biomedical Materials Research. 2002;63(3):252–261. [PubMed] 10. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. Journal of Bone and Mineral Research. 1998;13(5):793–802. [PubMed] 11. Anselme K, Bigerelle M. Topography effects of pure titanium substrates on human osteoblast long-term adhesion. Acta Biomaterialia. 2005;1(2):211–222. [PubMed] 12. Anselme K, Bigerelle M. Statistical demonstration of the relative effect of surface chemistry and roughness on human osteoblast short-term adhesion. Journal of Materials Science: Materials in Medicine. 2006;17(5):471–479. [PubMed] 13. Anselme K, Noël B, Hardouin P. Human osteoblast adhesion on titanium alloy, stainless steel, glass and plastic substrates with same surface topography. Journal of Materials Science: Materials in Medicine. 1999;10(12):815–819. [PubMed] 14. Bigerelle M, Anselme K. Statistical correlation between cell adhesion and proliferation on biocompatible metallic materials. Journal of Biomedical Materials Research Part A. 2005;72(1):36–46. [PubMed] 15. Bigerelle M, Anselme K. A kinetic approach to osteoblast adhesion on biomaterial surface. Journal of Biomedical Materials Research Part A. 2005;75(3):530–540. [PubMed] 16. Pérez-Willard F, Wolde-Giorgis D, Al-Kassab T, et al. Focused ion beam preparation of atom probe specimens containing a single crystallographically well-defined grain boundary. to appear in Micron
. 17. Meyer U, Büchter A, Wiesmann HP, Joos U, Jones DB. Basic reactions of osteoblasts on structured material surfaces. European Cells & Materials. 2005;9:39–49. [PubMed] 18. Teixeira S, Monteiro FJ, Ferraz MP, Vilar R, Eugeénio S. Laser surface treatment of hydroxyapatite for enhanced tissue integration: surface characterization and
osteoblastic interaction studies. Journal of Biomedical Materials Research Part A. 2007;81(4):920–929. [PubMed] 19. Bigerelle M, Anselme K, Dufresne E, Hardouin P, Iost A. An unscaled parameter to measure the order of surfaces: a new surface elaboration to increase cells adhesion. Biomolecular Engineering. 2002;19(2–6):79–83. [PubMed] 20. Anselme K, Bigerelle M, Loison I, Noël B, Hardouin P. Kinetic study of the expression of 21. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials. 2000;21(17):1803–1810. [PubMed] 22. Kaplan F, Hayes W, Keaveny T, Boskey A, Einhorn T, Iannotti J. Influence of titanium surfaces on attachment of osteoblast-like cells in vitro. In: Sp S, editor. Orthopedic Basic Science. American Academy of Orthopedic Surgeons; 1994. pp. 460–478. 23. Grizon F, Aguado E, Huré G, Baslé MF, Chappard D. Enhanced bone integration of implants with increased surface roughness: a long term study in the sheep. Journal of Dentistry. 2002;30(5-6):195–203. [PubMed] 24. Phillips TW, Messieh SS. Cementless hip replacement for arthritis. Problems with a smooth surface Moore stem. Journal of Bone and Joint Surgery, British. 1988;70(5):750–755. 25. Shalabi MM, Gortemaker A, Van't Hof MA, Jansen JA, Creugers NHJ. Implant surface roughness and bone healing: a systematic review. Journal of Dental Research. 2006;85(6):496–500. [PubMed] 26. Jäger M, Fischer T, Schultheis A, Lensing-Höhn S, Krauspe R. Extensive 27. Jäger M, Wilke A. Comprehensive biocompatibility testing of a new PMMA-HA bone cement versus conventional PMMA cement in vitro. Journal of Biomaterials Science, Polymer Edition. 2003;14(11):1283–1298. [PubMed] 28. Jayaraman M, Meyer U, Bühner M, Joos U, Wiesmann H-P. Influence of titanium surfaces on attachment of osteoblast-like cells in vitro. Biomaterials. 2004;25(4):625–631. [PubMed] 29. Martin JY, Schwartz Z, Hummert TW, et al. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human
osteoblast-like cells (MG63). Journal of Biomedical Materials Research. 1995;29(3):389–401. [PubMed] 30. Schwartz Z, Boyan BD. Underlying mechanisms at the bone-biomaterial interface. Journal of Cellular Biochemistry. 1994;56(3):340–347. [PubMed] 31. Schwartz Z, Kieswetter K, Dean DD, Boyan BD. Underlying mechanisms at the bone-surface interface during regeneration. Journal of Periodontal Research. 1997;32(1, part 2):166–171. [PubMed] 32. Cooper LF. A role for surface topography in creating and maintaining bone at titanium endosseous implants. Journal of Prosthetic Dentistry. 2000;84(5):522–534. [PubMed] 33. Macdonald W, Campbell P, Fisher J, Wennerberg A. Variation in surface texture measurements. Journal of Biomedical Materials Research Part B. 2004;70(2):262–269. 34. Andrade JD, Hlady V. Plasma protein adsorption: the big twelve. Annals of the New York Academy of Sciences. 1987;516:158–172. [PubMed] 35. Hakansson M, Linse S. Protein reconstitution and 3D domain swapping. Current Protein and Peptide Science. 2002;3(6):629–642. [PubMed] 36. Iuliano DJ, Saavedra SS, Truskey GA. Effect of the conformation and orientation of adsorbed fibronectin on endothelial cell spreading
and the strength of adhesion. Journal of Biomedical Materials Research. 1993;27(8):1103–1113. [PubMed] 37. Steele JG, Dalton BA, Johnson G, Underwood PA. Adsorption of fibronectin and vitronectin onto 38. Vroman L. The importance of surfaces in contact phase reactions. Seminars in Thrombosis and Hemostasis. 1987;13(1):79–85. [PubMed] 39. Balcerzak M, Hamade E, Zhang L, et al. The roles of annexins and alkaline phosphatase in mineralization process. Acta Biochimica Polonica. 2003;50(4):1019–1038. [PubMed] 40. Pavalko FM, Norvell SM, Burr DB, Turner CH, Duncan RL, Bidwell JP. A model for mechanotransduction in bone cells: the load-bearing mechanosomes. Journal of Cellular Biochemistry. 2003;88(1):104–112. [PubMed] 41. Weyts FA, Bosmans B, Niesing R, van Leeuwen JP, Weinans H. Mechanical control of human osteoblast apoptosis and proliferation in relation to differentiation. Calcified Tissue International. 2003;72(4):505–512. [PubMed] 42. Ingber DE. Mechanobiology and diseases of mechanotransduction. Annals of Medicine. 2003;35(8):564–577. [PubMed] 43. Coppolino MG, Dedhar S. Bi-directional signal transduction by integrin receptors. The International Journal of Biochemistry and Cell Biology. 2000;32(2):171–188. 44. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285(5430):1028–1032. [PubMed] 45. Howe A, Aplin AE, Alahari SK, Juliano R. Integrin signaling and cell growth control. Current Opinion in Cell Biology. 1998;10(2):220–231. [PubMed] 46. Meyer U, Meyer T, Jones DB. Attachment kinetics, proliferation rates and vinculin assembly of bovine osteoblasts cultured on
different pre-coated artificial substrates. Journal of Materials Science: Materials in Medicine. 1998;9(6):301–307. [PubMed] 47. Moursi AM, Globus RK, Damsky CH. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. Journal of Cell Science. 1997;110(18):2187–2196. [PubMed] 48. Rezania A, Healy KE. The effect of peptide surface density on mineralization of a matrix deposited by osteogenic cells. Journal of Biomedical Materials Research. 2000;52(4):595–600. [PubMed] 49. Boyan BD, Hummert TW, Dean DD, Schwartz Z. Role of material surfaces in regulating bone and cartilage cell response. Biomaterials. 1996;17(2):137–146. [PubMed] 50. Rouahi M, Champion E, Gallet O, Jada A, Anselme K. Physico-chemical characteristics and protein adsorption potential of hydroxyapatite particles:
influence on in vitro biocompatibility of ceramics after sintering. Colloids and Surfaces B. 2006;47(1):10–19. 51. Webb K, Hlady V, Tresco PA. Relationships among cell attachment, spreading, cytoskeletal organization, and migration rate for
anchorage-dependent cells on model surfaces. Journal of Biomedical Materials Research. 2000;49(3):362–368. [PubMed] 52. Schweikl H, Müller R, Englert C, et al. Proliferation of osteoblasts and fibroblasts on model surfaces of varying roughness and surface chemistry. Journal of Materials Science: Materials in Medicine. 2007 53. El-Ghannam AR, Ducheyne P, Risbud M, et al. Model surfaces engineered with nanoscale roughness and RGD tripeptides promote osteoblast activity. Journal of Biomedical Materials Research Part A. 2004;68(4):615–627. [PubMed] 54. Andrade JD. Interfacial phenomena and biomaterials. Medical Instrumentation. 1973;7(2):110–119. [PubMed] 55. Heide H, Jones DB, Meyer U, Möller K, Priessnitz B, Szulczewski DH. The influence of zeta-potential and interfacial-tension on osteoblast-like cells. Cells and Materials. 1994;4(3):263–274. 56. Lim YJ, Oshida Y. Initial contact angle measurements on variously treated dental/medical titanium materials. Bio-Medical Materials and Engineering. 2001;11(4):325–341. [PubMed] 57. Jäger M, Urselmann F, Witte F, et al. Osteoblast differentiation onto different biometals with a endoprosthetic surface geometry in vitro. to appear in Journal of Biomedical Materials Research Part A
. 58. Redey SA, Nardin M, Bernache-Assolant D, et al. Behavior of human osteoblastic cells on stoichiometric hydroxyapatite and type A carbonate apatite: role of surface energy. Journal of Biomedical Materials Research. 2000;50(3):353–364. [PubMed] 59. Zhao G, Schwartz Z, Wieland M, et al. High surface energy enhances cell response to titanium substrate microstructure. Journal of Biomedical Materials Research Part A. 2005;74(1):49–58. [PubMed] 60. Stock C, Yang Y, Ong J. Protein adsorption and cell adhesion on different implant metals. The IADR/AADR/CADR 83rd General Session; 2005 March; Baltimore, Md, USA. 61. Bumgardner JD, Wiser R, Elder SH, Jouett R, Yang Y, Ong JL. Contact angle, protein adsorption and osteoblast precursor cell attachment to chitosan coatings bonded to titanium. Journal of Biomaterials Science, Polymer Edition. 2003;14(12):1401–1409. [PubMed] 62. Qu Z, Rausch-Fan X, Wieland M, Matejka M, Schedle A. The initial attachment and subsequent behavior regulation of osteoblasts by dental implant surface modification. Journal of Biomedical Materials Research Part A. 2007;82(3):658–668. [PubMed] 63. Kern T, Yang Y, Glover R, Ong JL. Effect of heat-treated titanium surfaces on protein adsorption and osteoblast precursor cell initial attachment. Implant Dentistry. 2005;14(1):70–76. [PubMed] 64. MacDonald DE, Rapuano BE, Deo N, Stranick M, Somasundaran P, Boskey AL. Thermal and chemical modification of titanium-aluminum-vanadium implant materials:
effects on surface properties, glycoprotein adsorption, and MG63 cell attachment. Biomaterials. 2004;25(16):3135–3146. [PubMed] 65. García AJ, Boettiger D. Integrin-fibronectin interactions at the cell-material interface: initial integrin binding and signaling. Biomaterials. 1999;20(23-24):2427–2433. [PubMed] 66. de Oliveira PT, Nanci A. Nanotexturing of titanium-based surfaces upregulates expression of bone sialoprotein and
osteopontin by cultured osteogenic cells. Biomaterials. 2004;25(3):403–413. [PubMed] 67. Webster TJ, Ejiofor JU. Increased osteoblast adhesion on nanophase metals: Ti, Ti6Al4V, and CoCrMo. Biomaterials. 2004;25(19):4731–4739. [PubMed] 68. Das K, Bose S, Bandyopadhyay A. Surface modifications and cell-materials interactions with anodized Ti. Acta Biomaterialia. 2007;3(4):573–585. [PubMed] 69. Kim KH, Kwon TY, Kim SY, et al. Preparation and characterization of anodized titanium surfaces and their effect on osteoblast responses. The Journal of Oral Implantology. 2006;32(1):8–13. [PubMed] 70. Park J-M, Koak J-Y, Jang J-H, Han C-H, Kim S-K, Heo S-J. Osseointegration of anodized titanium implants coated with fibroblast growth factor-fibronectin (FGF-FN) fusion protein. International Journal of Oral and Maxillofacial Implants. 2006;21(6):859–866. [PubMed] 71. Sohn S-H, Jun H-K, Kim C-S, et al. Biological responses in osteoblast-like cell line according to thin layer hydroxyapatite coatings on anodized titanium. Journal of Oral Rehabilitation. 2006;33(12):898–911. [PubMed] 72. Rouahi M, Gallet O, Champion E, Dentzer J, Hardouin P, Anselme K. Influence of hydroxyapatite microstructure on human bone cell response. Journal of Biomedical Materials Research Part A. 2006;78(2):222–235. [PubMed] 73. Chun AL, Moralez JG, Webster TJ, Fenniri H. Helical rosette nanotubes: a biomimetic coating for orthopedics? Biomaterials. 2005;26(35):7304–7309. [PubMed] 74. Fenniri H, Mathivanan P, Vidale KL, et al. Helical rosette nanotubes: design, self-assembly, and characterization. Journal of the American Chemical Society. 2001;123(16):3854–3855. [PubMed] 75. Toworfe GK, Composto RJ, Adams CS, Shapiro IM, Ducheyne P. Fibronectin adsorption on surface-activated poly(dimethylsiloxane) and its effect on cellular function. Journal of Biomedical Materials Research Part A. 2004;71(3):449–461. [PubMed] 76. von Recum AF, van Kooten TG. The influence of micro-topography on cellular response and the implications for silicone implants. Journal of Biomaterials Science. 1995;7(2):181–198. 77. Yang Y, Cavin R, Ong JL. Protein adsorption on titanium surfaces and their effect on osteoblast attachment. Journal of Biomedical Materials Research Part A. 2003;67(1):344–349. [PubMed] 78. Bierbaum S, Beutner R, Hanke T, Scharnweber D, Hempel U, Worch H. Modification of Ti6Al4V surfaces using collagen I, III, and fibronectin—I: biochemical and morphological characteristics of the adsorbed matrix. Journal of Biomedical Materials Research Part A. 2003;67(2):421–430. [PubMed] 79. Goldstein AS, DiMilla PA. Examination of membrane rupture as a mechanism for mammalian cell detachment from fibronectin-coated biomaterials. Journal of Biomedical Materials Research Part A. 2003;67(2):658–666. [PubMed] 80. van den Dolder J, Bancroft GN, Sikavitsas VI, Spauwen PHM, Mikos AG, Jansen JA. Effect of fibronectin- and collagen I-coated titanium fiber mesh on proliferation and differentiation of osteogenic cells. Tissue Engineering. 2003;9(3):505–515. [PubMed] 81. Cornell R. Cell-substrate adhesion during cell culture. An ultrastructural study. Experimental Cell Research. 1969;58(2-3):289–295. [PubMed] 82. Curtis ASG, Varde M. Control of cell behavior: topological factors. Journal of the National Cancer Institute. 1964;33:15–26. [PubMed] 83. Abercrombie M, Heaysman JE, Pegrum SM. The locomotion of fibroblasts in culture—IV: electron microscopy of the leading lamella. Experimental Cell Research. 1971;67(2):359–367. [PubMed] 84. Izzard CS, Lochner LR. Cell to substrate contacts in living fibroblasts: an interference reflexion study with an evaluation of the technique. Journal of Cell Science. 1976;21(1):129–159. [PubMed] 85. Balaban NQ, Schwartz US, Riveline D, et al. Force and focal adhesion assembly: a close relationship studied using elastic micropatterned substrates. Nature Cell Biology. 2001;3(5):466–472. 86. Bigerelle M, Anselme K. Bootstrap analysis of the relation between initial adhesive events and long-term cellular functions of human osteoblasts cultured on biocompatible metallic substrates. Acta Biomaterialia. 2005;1(5):499–510. [PubMed] 87. Wan Y, Wang Y, Liu Z, et al. Adhesion and proliferation of OCT-1 osteoblast-like cells on micro- and nano-scale topography structured poly(L-lactide). Biomaterials. 2005;26(21):4453–4459. [PubMed] 88. Badami AS, Kreke MR, Thompson MS, Riffle JS, Goldstein AS. Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates. Biomaterials. 2006;27(4):596–606. [PubMed] 89. Ikarashi Y, Tsuchiya T, Kaniwa M, Nakamura A. Activation of osteoblast-like MC3T3-E1 cell responses by poly(lactide). Biological and Pharmaceutical Bulletin. 2000;23(12):1470–1476. [PubMed] 90. Isama K, Tsuchiya T. Enhancing effect of poly(L-lactide) on the differentiation of mouse osteoblast-like MC3T3-E1 cells. Biomaterials. 2003;24(19):3303–3309. [PubMed] 91. Liu H, Slamovich EB, Webster TJ. Increased osteoblast functions among nanophase titania/poly(lactide-co-glycolide) composites of the highest nanometer surface roughness. Journal of Biomedical Materials Research Part A. 2006;78(4):798–807. [PubMed] 92. Woo KM, Jun J-H, Chen VJ, et al. Nano-fibrous scaffolding promotes osteoblast differentiation and biomineralization. Biomaterials. 2007;28(2):335–343. [PubMed] 93. Webster TJ, Smith TA. Increased osteoblast function on PLGA composites containing nanophase titania. Journal of Biomedical Materials Research Part A. 2005;74(4):677–686. [PubMed] 94. Diener A, Nebe B, Lüthen F, et al. Control of focal adhesion dynamics by material surface characteristics. Biomaterials. 2005;26(4):383–392. [PubMed] 95. Benoit DSW, Anseth KS. The effect on osteoblast function of colocalized RGD and PHSRN epitopes on PEG surfaces. Biomaterials. 2005;26(25):5209–5220. [PubMed] 96. Biebuyck HA, Whitesides GM. Self-organization of organic liquids on patterned self-assembled monolayers of alkanethiolates on gold. Langmuir. 1994;10(8):2790–2793. 97. Gau H, Herminghaus S, Lenz P, Lipowsky R. Liquid morphologies on structured surfaces: from microchannels to microchips. Science. 1999;283(5398):46–49. [PubMed] 98. Kim E, Xia Y, Whitesides GM. Polymer microstructures formed by moulding in capillaries. Nature. 1995;376(6541):581–584. 99. Morra M, Cassinelli C, Cascardo G, et al. Surface engineering of titanium by collagen immobilization. Surface characterization and in vitro and in vivo studies. Biomaterials. 2003;24(25):4639–4654. [PubMed] 100. Sarikaya M, Tamerler C, Jen AK-Y, Schulten K, Baneyx F. Molecular biomimetics: nanotechnology through biology. Nature Materials. 2003;2(9):577–585. 101. Xia Y, Whitesides GM. Extending microcontact printing as a microlithographic technique. Langmuir. 1997;13(7):2059–2067. 102. Zhang S, Marini DM, Hwang W, Santoso S. Design of nanostructured biological materials through self-assembly of peptides and proteins. Current Opinion in Chemical Biology. 2002;6(6):865–871. [PubMed] 103. Cutler SM, García AJ. Engineering cell adhesive surfaces that direct integrin 104. Nagai M, Hayakawa T, Fukatsu A, et al. In vitro study of collagen coating of titanium implants for initial cell attachment. Dental Materials Journal. 2002;21(3):250–260. [PubMed] 105. Schliephake H, Scharnweber D, Dard M, Rößler S, Sewing A, Hüttmann C. Biological performance of biomimetic calcium phosphate coating of titanium implants in the dog mandible. Journal of Biomedical Materials Research Part A. 2003;64(2):225–234. [PubMed] 106. Shi H, Tsai W-B, Garrison MD, Ferrari S, Ratner BD. Template-imprinted nanostructured surfaces for protein recognition. Nature. 1999;398(6728):593–597. [PubMed] 107. Danen EHJ, Aota S-I, van Kraats AA, Yamada KM, Ruiter DJ, van Muijen GNP. Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin 108. Huveneers S, van den Bout I, Sonneveld P, Sancho A, Sonnenberg A, Danen EHJ. Integrin 109. Keselowsky BG, Bridges AW, Burns KL, et al. Role of plasma fibronectin in the foreign body response to biomaterials. Biomaterials. 2007;28(25):3626–3631. [PubMed] 110. Keselowsky BG, Collard DM, García AJ. Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. Journal of Biomedical Materials Research Part A. 2003;66(2):247–259. [PubMed] 111. Keselowsky BG, Collard DM, García AJ. Surface chemistry modulates focal adhesion composition and signaling through changes in integrin binding. Biomaterials. 2004;25(28):5947–5954. [PubMed] 112. Keselowsky BG, Collard DM, García AJ. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(17):5953–5957. [PubMed] 113. Keselowsky BG, Wang L, Schwartz Z, García AJ, Boyan BD. Integrin 114. Anselme K. Osteoblast adhesion on biomaterials. Biomaterials. 2000;21(7):667–681. [PubMed] 115. Kononen M, Hormia M, Kivilahti J, Hautaniemi J, Thesleff I. Effect of surface processing on the attachment, orientation, and proliferation of human gingival fibroblasts on titanium. Journal of Biomedical Materials Research. 1992;26(10):1325–1341. [PubMed] 116. Li D, Liu B, Wu J, Chen J. Bone interface of dental implants cytologically influenced by a modified sandblasted surface: a preliminary in vitro study. Implant Dentistry. 2001;10(2):132–138. [PubMed] 117. Curtis ASG, Wilkinson C. Nantotechniques and approaches in biotechnology. Trends in Biotechnology. 2001;19(3):97–101. [PubMed] 118. Dalby MJ, Di Silvio L, Davies GW, Bonfield W. Surface topography and HA filler volume effect on primary human osteoblasts in vitro. Journal of Materials Science: Materials in Medicine. 2000;11(12):805–810. [PubMed] 119. Wang J-H, Yao C-H, Chuang W-Y, Young T-H. Development of biodegradable polyesterurethane membranes with different surface morphologies for the culture of osteoblasts. Journal of Biomedical Materials Research. 2000;51(4):761–770. [PubMed] 120. Domke J, Dannöhl S, Parak WJ, Müller O, Aicher WK, Radmacher M. Substrate dependent differences in morphology and elasticity of living osteoblasts investigated by atomic force microscopy. Colloids and Surfaces B. 2000;19(4):367–379. 121. Gleiche M, Chi LF, Fuchs H. Nanoscopic channel lattices with controlled anisotropic wetting. Nature. 2000;403(6766):173–175. [PubMed] 122. Lenhert S, Meier M-B, Meyer U, Chi L, Wiesmann HP. Osteoblast alignment, elongation and migration on grooved polystyrene surfaces patterned by Langmuir-Blodgett lithography. Biomaterials. 2005;26(5):563–570. [PubMed] 123. Martines E, McGhee K, Wilkinson C, Curtis ASG. A parallel-plate flow chamber to study initial cell adhesion on a nano featured surface. IEEE Transactions on Nanobioscience. 2004;3(2):90–95. [PubMed] 124. Mustafa K, Wennerberg A, Wroblewski J, Hultenby K, Lopez BS, Arvidson K. Determining optimal surface roughness of 125. Mustafa K, Wroblewski J, Hultenby K, Lopez BS, Arvidson K. Effects of titanium surfaces blasted with 126. Anselme K, Bigerelle M, Noel B, et al. Qualitative and quantitative study of human osteoblast adhesion on materials with various surface roughnesses. Journal of Biomedical Materials Research. 1999;49(2):155–166. [PubMed] 127. Eisenbarth E, Velten D, Müller M, Thull R, Breme J. Nanostructured niobium oxide coatings influence osteoblast adhesion. Journal of Biomedical Materials Research Part A. 2006;79(1):166–175. [PubMed] 128. Kim H-W, Kim H-E, Knowles JC. Fluor-hydroxyapatite sol-gel coating on titanium substrate for hard tissue implants. Biomaterials. 2004;25(17):3351–3358. [PubMed] 129. Oh S, Daraio C, Chen L-H, Pisanic TR, Fiñones RR, Jin S. Significantly accelerated osteoblast cell growth on aligned 130. Veis AA, Papadimitriou S, Trisi P, Tsirlis AT, Parissis NA, Kenealy JN. Osseointegration of 131. Persson LG, Mouhyi J, Berglundh T, Sennerby L, Lindhe J. Carbon dioxide laser and hydrogen peroxide conditioning in the treatment of periimplantitis: an experimental study in the dog. Clinical Implant Dentistry and Related Research. 2004;6(4):230–238. [PubMed] 132. Zhu L, Ye X, Tang G, et al. Biomimetic coating of compound titania and hydroxyapatite on titanium. Journal of Biomedical Materials Research Part A. 2007 133. Mancini L, Tamma R, Settanni MP, et al. Osteoblasts cultured on three-dimensional synthetic hydroxyapatite implanted on a chick Allantochorial membrane induce ectopic bone marrow differentiation. Annals of the New York Academy of Sciences. 2007 134. Yang CY, Lee TM, Yang CW, Chen LR, Wu MC, Lui TS. In vitro and in vivo biological responses of plasma-sprayed hydroxyapatite coatings with posthydrothermal treatment. Journal of Biomedical Materials Research Part A. 2007 135. Curtis ASG, Wilkinson C. New depths in cell behaviour: reactions of cells to nanotopography. Biochemical Society Symposium. 1999;65:15–26. [PubMed] 136. Dalby MJ, Yarwood SJ, Riehle MO, Johnstone HJH, Affrossman S, Curtis ASG. Increasing fibroblast response to materials using nanotopography: morphological and genetic measurements of cell response to 13-nm-high polymer demixed islands. Experimental Cell Research. 2002;276(1):1–9. [PubMed] 137. Scotchford CA, Ball M, Winkelmann M, et al. Chemically patterned, metal-oxide-based surfaces produced by photolithographic techniques for studying protein- and cell-interactions—II: protein adsorption and early cell interactions. Biomaterials. 2003;24(7):1147–1158. [PubMed] 138. Rice JM, Hunt JA, Gallagher JA, Hanarp P, Sutherland DS, Gold J. Quantitative assessment of the response of primary derived human osteoblasts and macrophages to a range of nanotopography surfaces in a single culture model in vitro. Biomaterials. 2003;24(26):4799–4818. [PubMed] 139. Rouahi M, Champion E, Hardouin P, Anselme K. Quantitative kinetic analysis of gene expression during human osteoblastic adhesion on orthopaedic materials. Biomaterials. 2006;27(14):2829–2844. [PubMed] 140. Hendrich C, Nöth U, Stahl U, et al. Testing of skeletal implant surfaces with human fetal osteoblasts. Clinical Orthopaedics & Related Research. 2002;(394):278–289. [PubMed] 141. Hallgren C, Reimers H, Gold J, Wennerberg A. The importance of surface texture for bone integration of screw shaped implants: an in vivo study of implants patterned by photolithography. Journal of Biomedical Materials Research. 2001;57(4):485–496. [PubMed] 142. Hamilton DW, Wong KS, Brunette DM. Microfabricated discontinuous-edge surface topographies influence osteoblast adhesion, migration, cytoskeletal organization, and proliferation and enhance matrix and mineral deposition in vitro. Calcified Tissue International. 2006;78(5):314–325. [PubMed] 143. Germanier Y, Tosatti S, Broggini N, Textor M, Buser D. Enhanced bone apposition around biofunctionalized sandblasted and acid-etched titanium implant surfaces: a histomorphometric study in miniature pigs. Clinical Oral Implants Research. 2006;17(3):251–257. [PubMed] 144. Rammelt S, Illert T, Bierbaum S, Scharnweber D, Zwipp H, Schneiders W. Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate. Biomaterials. 2006;27(32):5561–5571. [PubMed] 145. Slaets E, Carmeliet G, Naert I, Duyck J. Early cellular responses in cortical bone healing around unloaded titanium implants: an animal study. Journal of Periodontology. 2006;77(6):1015–1024. [PubMed] 146. Vallés G, González-Melendi P, González-Carrasco JL, et al. Differential inflammatory macrophage response to rutile and titanium particles. Biomaterials. 2006;27(30):5199–5211. [PubMed] 147. Müller U, Imwinkelried T, Horst M, Sievers M, Graf-Hausner U. Do human osteoblasts grow into open-porous titanium? European Cells and Materials. 2006;11:8–15. [PubMed] 148. Li JP, Li SH, Van Blitterswijk CA, de Groot K. A novel porous Ti6A14V: characterization and cell attachment. Journal of Biomedical Materials Research Part A. 2005;73(2):223–233. [PubMed] 149. Ward BC, Webster T. Effect of metal substrate nanometer topography on osteoblast metabolic activities. Biological and Bioinspired Materials and Devices; Materials Research Society; 2004. Apr, pp. 249–254. 150. Ward BC, Webster T. Effect of metal substrate nanometer topography on osteoblast metabolic activities. TMS Conference Proceedings; 2005. pp. 13–17. 151. Bibby JK, Bubb NL, Wood DJ, Mummery PM. Fluorapatite-mullite glass sputter coated Ti6Al4V for biomedical applications. Journal of Materials Science. 2005;16(5):379–385. [PubMed] 152. Isa ZM, Schneider GB, Zaharias R, Seabold D, Stanford CM. Effects of fluoride-modified titanium surfaces on osteoblast proliferation and gene expression. The International Journal of Oral & Maxillofacial Implants. 2006;21(2):203–211. 153. Ber S, Torun Köse G, Hasirci V. Bone tissue engineering on patterned collagen films: an in vitro study. Biomaterials. 2005;26(14):1977–1986. [PubMed] 154. García AJ, Reyes CD. Bio-adhesive surfaces to promote osteoblast differentiation and bone formation. Journal of Dental Research. 2005;84(5):407–413. [PubMed] 155. Jäger M, Feser T, Denck H, Krauspe R. Proliferation and osteogenic differentiation of mesenchymal stem cells cultured onto three different polymers in vitro. Annals of Biomedical Engineering. 2005;33(10):1319–1332. [PubMed] 156. Yonggang Y, Wolke JG, Yubao L, Jansen JA. In vitro evaluation of different heat-treated radio frequency magnetron sputtered calcium phosphate coatings. Clinical Oral Implants Research. 2007;18(3):345–353. [PubMed] 157. Baumann B, Rader CP, Seufert J, et al. Effects of polyethylene and TiAIV wear particles on expression of RANK, RANKL and OPG mRNA. Acta Orthopaedica Scandinavica. 2004;75(3):295–302. [PubMed] 158. Huang J, Best SM, Bonfield W, et al. In vitro assessment of the biological response to nano-sized hydroxyapatite. Journal of Materials Science. 2004;15(4):441–445. [PubMed] 159. Peters K, Unger RE, Kirkpatrick CJ, Gatti AM, Monari E. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. Journal of Materials Science. 2004;15(4):321–325. [PubMed] 160. Bruni S, Martinesi M, Stio M, Treves C, Bacci T, Borgioli F. Effects of surface treatment of Ti-6AI-4V titanium alloy on biocompatibility in cultured human umbilical vein endothelial cells. Acta Biomaterialia. 2005;1(2):223–234. [PubMed] 161. Eriksson AS, Thomsen P. Leukotriene 162. Giudiceandrea F, Iacona A, Cervelli G, et al. Mechanisms of bone resorption: analysis of proinflammatory cytokines in peritoneal macrophages from titanium implant—an experimental design. Journal of Craniofacial Surgery. 1998;9(3):254–259. [PubMed] 163. Martinesi M, Bruni S, Stio M, Treves C, Borgioli F. In vitro interaction between surface-treated Ti-6Al-4V titanium alloy and human peripheral blood mononuclear cells. Journal of Biomedical Materials Research Part A. 2005;74(2):197–207. [PubMed] 164. Refai AK, Textor M, Brunette DM, Waterfield JD. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines. Journal of Biomedical Materials Research Part A. 2004;70(2):194–205. [PubMed] 165. Brodbeck WG, Patel J, Voskerician G, et al. Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(16):10287–10292. [PubMed] 166. Morais S, Dias N, Sousa JP, Fernandes MH, Carvalho GS. In vitro osteoblastic differentiation of human bone marrow cells in the presence of metal ions. Journal of Biomedical Materials Research. 1999;44(2):176–190. [PubMed] 167. Morais S, Sousa JP, Fernandes MH, Carvalho GS, de Bruijn JD, van Blitterswijk CA. Effects of AISI 316L corrosion products in in vitro bone formation. Biomaterials. 1998;19(11-12):999–1007. [PubMed] 168. Puleo DA, Huh WW. Acute toxicity of metal ions in cultures of osteogenic cells derived from bone marrow stromal cells. Journal of Applied Biomaterials. 1995;6(2):109–116. [PubMed] 169. Lin H-Y, Bumgardner JD. Changes in the surface oxide composition of Co-Cr-Mo implant alloy by macrophage cells and their released reactive chemical species. Biomaterials. 2004;25(7-8):1233–1238. [PubMed] 170. Lin H-Y, Bumgardner JD. In vitro biocorrosion of Ti-6AI-4V implant alloy by a mouse macrophage cell line. Journal of Biomedical Materials Research Part A. 2004;68(4):717–724. [PubMed] 171. Lin H-Y, Bumgardner JD. In vitro biocorrosion of Co-Cr-Mo implant alloy by macrophage cells. Journal of Orthopaedic Research. 2004;22(6):1231–1236. [PubMed] 172. Hunter A, Archer CW, Walker PS, Blunn GW. Attachment and proliferation of osteoblasts and fibroblasts on biomaterials for orthopaedic use. Biomaterials. 1995;16(4):287–295. [PubMed] 173. Kuroda S, Takeda S, Nakamura M. Effects of six particulate metals on osteoblast-like MG-63 and HOS cells in vitro. Dental Materials Journal. 2003;22(4):507–520. [PubMed] 174. Granchi D, Amato I, Battistelli L, et al. Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles. Biomaterials. 2005;26(15):2371–2379. [PubMed] 175. Rader CP, Baumann B, Rolf O, et al. Detection of differentially expressed genes in particle disease using array-filter analysis. Biomedizinische Technik. 2002;47(5):111–116. [PubMed] 176. O'Connor DT, Choi MG, Kwon SY, Paul Sung K-L. New insight into the mechanism of hip prosthesis loosening: effect of titanium debris size on osteoblast function. Journal of Orthopaedic Research. 2004;22(2):229–236. [PubMed] 177. Miyanishi K, Trindade MC, Ma T, Goodman SB, Schurman DJ, Smith RL. Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles. Journal of Bone and Mineral Research. 2003;18(9):1573–1583. [PubMed] 178. Nakashima Y, Sun D-H, Trindade MC, et al. Signaling pathways for tumor necrosis factor- 179. Dean DD, Schwartz Z, Liu Y, et al. The effect of ultra-high molecular weight polyethylene wear debris on MG-63 osteosarcoma cells in vitro. Journal of Bone and Joint Surgery, American. 1999;81(4):452–461. 180. Ingham E, Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials. 2005;26(11):1271–1286. [PubMed] 181. Green TR, Fisher J, Stone M, Wroblewski BM, Ingham E. Polyethylene particles of a ‘critical size’ are necessary for the induction of cytokines by macrophages in vitro. Biomaterials. 1998;19(24):2297–2302. [PubMed] 182. Yao J, Glant TT, Lark MW, et al. The potential role of fibroblasts in periprosthetic osteolysis: fibroblast response to titanium particles. Journal of Bone and Mineral Research. 1995;10(9):1417–1427. [PubMed] 183. Manlapaz M, Maloney WJ, Smith RL. In vitro activation of human fibroblasts by retrieved titanium alloy wear debris. Journal of Orthopaedic Research. 1996;14(3):465–472. [PubMed] 184. Shanbhag AS, Jacobs JJ, Black J, Galante JO, Giant TT. Effects of particles on fibroblast proliferation and bone resorption in vitro. Clinical Orthopaedics & Related Research. 1997;(342):205–217. [PubMed] 185. Santavirta S, Takagi M, Nordsletten L, Anttila A, Lappalainen R, Konttinen YT. Biocompatibility of silicon carbide in colony formation test in vitro: a promising new ceramic THR implant coating material. Archives of Orthopaedic and Trauma Surgery. 1998;118(1-2):89–91. [PubMed] 186. Sun J-S, Lin F-H, Hung T-Y, Tsuang Y-H, Chang WH-S, Liu H-C. The influence of hydroxyapatite particles on osteoclast cell activities. Journal of Biomedical Materials Research. 1999;45(4):311–321. [PubMed] 187. Green TR, Fisher J, Matthews JB, Stone MH, Ingham E. Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. Journal of Biomedical Materials Research. 2000;53(5):490–497. [PubMed] 188. Akisue T, Bauer TW, Farver CF, Mochida Y. The effect of particle wear debris on NF 189. Wilke A, Endres S, Griss P, Herz U. Cytokine profile of a human bone marrow cell culture on exposure to titanium-aluminium-vanadium particles. Zeitschrift für Orthopädie und Ihre Grenzgebiete. 2002;140(1):83–89. 190. Germain MA, Hatton A, Williams S, et al. Comparison of the cytotoxicity of clinically relevant cobalt-chromium and alumina ceramic wear particles in vitro. Biomaterials. 2003;24(3):469–479. [PubMed] 191. Howling GI, Sakoda H, Antonarulrajah A, et al. Biological response to wear debris generated in carbon based composites as potential bearing surfaces for artificial hip joints. Journal of Biomedical Materials Research Part B. 2003;67(2):758–764. 192. Granchi D, Ciapetti G, Amato I, et al. The influence of alumina and ultra-high molecular weight polyethylene particles on osteoblast-osteoclast cooperation. Biomaterials. 2004;25(18):4037–4045. [PubMed] 193. Howling GI, Ingham E, Sakoda H, et al. Carbon-carbon composite bearing materials in hip arthroplasty: analysis of wear and biological response to wear debris. Journal of Materials Science. 2004;15(1):91–98. [PubMed] 194. Barrias CC, Ribeiro CC, Lamghari M, Miranda CS, Barbosa MA. Proliferation, activity, and osteogenic differentiation of bone marrow stromal cells cultured on calcium titanium phosphate microspheres. Journal of Biomedical Materials Research Part A. 2005;72(1):57–66. [PubMed] 195. Petit A, Mwale F, Antoniou J, Zukor DJ, Huk OL. Effect of bisphosphonates on the stimulation of macrophages by alumina ceramic particles: a comparison with ultra-high-molecular-weight polyethylene. Journal of Materials Science. 2006;17(7):667–673. [PubMed] 196. Tan WB, Huang N, Zhang Y. Ultrafine biocompatible chitosan nanoparticles encapsulating multi-coloured quantum dots for bioapplications. Journal of Colloid and Interface Science. 2007;310(2):464–470. [PubMed] 197. Sayes CM, Liang F, Hudson JL, et al. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicology Letters. 2006;161(2):135–142. [PubMed] 198. Koyama S, Haniu H, Osaka K, et al. Medical application of carbon-nanotube-filled nanocomposites: the microcatheter. Small. 2006;2(12):1406–1411. [PubMed] 199. Liopo AV, Stewart MP, Hudson J, Tour JM, Pappas TC. Biocompatibility of native and functionalized single-walled carbon nanotubes for neuronal interface. Journal of Nanoscience and Nanotechnology. 2006;6(5):1365–1374. [PubMed] 200. Nahar M, Dutta T, Murugesan S, et al. Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives. Critical Reviews in Therapeutic Drug Carrier Systems. 2006;23(4):259–318. [PubMed] 201. Warashina H, Sakano S, Kitamura S, et al. Biological reaction to alumina, zirconia, titanium and polyethylene particles implanted onto murine calvaria. Biomaterials. 2003;24(21):3655–3661. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biomaterials. 2006 Jun; 27(16):3064-74.
[Biomaterials. 2006]J Am Chem Soc. 2003 Apr 16; 125(15):4451-9.
[J Am Chem Soc. 2003]Biomaterials. 2003 Aug; 24(19):3193-9.
[Biomaterials. 2003]J Biomed Mater Res. 2002; 63(3):252-61.
[J Biomed Mater Res. 2002]J Am Chem Soc. 2003 Apr 16; 125(15):4451-9.
[J Am Chem Soc. 2003]Acta Biomater. 2005 Mar; 1(2):211-22.
[Acta Biomater. 2005]Biomol Eng. 2002 Aug; 19(2-6):79-83.
[Biomol Eng. 2002]Biomed Mater Eng. 2004; 14(4):545-56.
[Biomed Mater Eng. 2004]Biomaterials. 2000 Sep; 21(17):1803-10.
[Biomaterials. 2000]J Dent. 2002 Jul-Aug; 30(5-6):195-203.
[J Dent. 2002]J Dent Res. 2006 Jun; 85(6):496-500.
[J Dent Res. 2006]J Biomed Mater Res A. 2006 Feb; 76(2):310-22.
[J Biomed Mater Res A. 2006]J Periodontal Res. 1997 Jan; 32(1 Pt 2):166-71.
[J Periodontal Res. 1997]J Prosthet Dent. 2000 Nov; 84(5):522-34.
[J Prosthet Dent. 2000]Eur Cell Mater. 2005 Apr 26; 9():39-49.
[Eur Cell Mater. 2005]Ann N Y Acad Sci. 1987; 516():158-72.
[Ann N Y Acad Sci. 1987]Curr Protein Pept Sci. 2002 Dec; 3(6):629-42.
[Curr Protein Pept Sci. 2002]Biomaterials. 1995 Sep; 16(14):1057-67.
[Biomaterials. 1995]Semin Thromb Hemost. 1987 Jan; 13(1):79-85.
[Semin Thromb Hemost. 1987]J Mater Sci Mater Med. 1998 Jun; 9(6):301-7.
[J Mater Sci Mater Med. 1998]J Biomed Mater Res. 2000 Dec 15; 52(4):595-600.
[J Biomed Mater Res. 2000]Biomaterials. 1996 Jan; 17(2):137-46.
[Biomaterials. 1996]J Cell Biochem. 1994 Nov; 56(3):340-7.
[J Cell Biochem. 1994]J Biomed Mater Res. 2000 Mar 5; 49(3):362-8.
[J Biomed Mater Res. 2000]J Biomed Mater Res A. 2004 Mar 15; 68(4):615-27.
[J Biomed Mater Res A. 2004]Med Instrum. 1973 Mar-Apr; 7(2):110-9.
[Med Instrum. 1973]Biomed Mater Eng. 2001; 11(4):325-41.
[Biomed Mater Eng. 2001]J Biomed Mater Res A. 2005 Jul 1; 74(1):49-58.
[J Biomed Mater Res A. 2005]J Biomater Sci Polym Ed. 2003; 14(12):1401-9.
[J Biomater Sci Polym Ed. 2003]J Biomed Mater Res A. 2007 Sep 1; 82(3):658-68.
[J Biomed Mater Res A. 2007]Implant Dent. 2005 Mar; 14(1):70-6.
[Implant Dent. 2005]Biomaterials. 2004 Jul; 25(16):3135-46.
[Biomaterials. 2004]Biomaterials. 1999 Dec; 20(23-24):2427-33.
[Biomaterials. 1999]Biomaterials. 2004 Feb; 25(3):403-13.
[Biomaterials. 2004]Biomaterials. 2004 Aug; 25(19):4731-9.
[Biomaterials. 2004]Acta Biomater. 2007 Jul; 3(4):573-85.
[Acta Biomater. 2007]J Oral Rehabil. 2006 Dec; 33(12):898-911.
[J Oral Rehabil. 2006]J Biomed Mater Res A. 2006 Aug; 78(2):222-35.
[J Biomed Mater Res A. 2006]Biomaterials. 2005 Dec; 26(35):7304-9.
[Biomaterials. 2005]J Am Chem Soc. 2001 Apr 25; 123(16):3854-5.
[J Am Chem Soc. 2001]J Biomed Mater Res A. 2004 Dec 1; 71(3):449-61.
[J Biomed Mater Res A. 2004]J Biomed Mater Res A. 2003 Oct 1; 67(1):344-9.
[J Biomed Mater Res A. 2003]J Biomed Mater Res A. 2003 Nov 1; 67(2):421-30.
[J Biomed Mater Res A. 2003]Tissue Eng. 2003 Jun; 9(3):505-15.
[Tissue Eng. 2003]Exp Cell Res. 1969 Dec; 58(2):289-95.
[Exp Cell Res. 1969]J Natl Cancer Inst. 1964 Jul; 33():15-26.
[J Natl Cancer Inst. 1964]Exp Cell Res. 1971 Aug; 67(2):359-67.
[Exp Cell Res. 1971]J Cell Sci. 1976 Jun; 21(1):129-59.
[J Cell Sci. 1976]Biomed Mater Eng. 2004; 14(4):545-56.
[Biomed Mater Eng. 2004]J Biomed Mater Res A. 2005 Jan 1; 72(1):36-46.
[J Biomed Mater Res A. 2005]J Biomed Mater Res A. 2005 Dec 1; 75(3):530-40.
[J Biomed Mater Res A. 2005]Acta Biomater. 2005 Sep; 1(5):499-510.
[Acta Biomater. 2005]Biomaterials. 2005 Jul; 26(21):4453-9.
[Biomaterials. 2005]Biomaterials. 2006 Feb; 27(4):596-606.
[Biomaterials. 2006]Biol Pharm Bull. 2000 Dec; 23(12):1470-6.
[Biol Pharm Bull. 2000]Biomaterials. 2007 Jan; 28(2):335-43.
[Biomaterials. 2007]J Biomed Mater Res A. 2005 Sep 15; 74(4):677-86.
[J Biomed Mater Res A. 2005]Biomaterials. 2005 Feb; 26(4):383-92.
[Biomaterials. 2005]J Mater Sci Mater Med. 1999 Dec; 10(12):815-9.
[J Mater Sci Mater Med. 1999]J Biomed Mater Res A. 2004 Mar 15; 68(4):615-27.
[J Biomed Mater Res A. 2004]Biomaterials. 2005 Sep; 26(25):5209-20.
[Biomaterials. 2005]Curr Opin Chem Biol. 2002 Dec; 6(6):865-71.
[Curr Opin Chem Biol. 2002]Biomaterials. 2003 May; 24(10):1759-70.
[Biomaterials. 2003]Nature. 1999 Apr 15; 398(6728):593-7.
[Nature. 1999]J Biol Chem. 1995 Sep 15; 270(37):21612-8.
[J Biol Chem. 1995]Cancer Res. 2007 Mar 15; 67(6):2693-700.
[Cancer Res. 2007]Biomaterials. 2007 Sep; 28(25):3626-31.
[Biomaterials. 2007]J Biomed Mater Res A. 2007 Mar 1; 80(3):700-10.
[J Biomed Mater Res A. 2007]J Cell Sci. 1997 Sep; 110 ( Pt 18)():2187-96.
[J Cell Sci. 1997]Proc Natl Acad Sci U S A. 2005 Apr 26; 102(17):5953-7.
[Proc Natl Acad Sci U S A. 2005]Trends Biotechnol. 2001 Mar; 19(3):97-101.
[Trends Biotechnol. 2001]J Biomed Mater Res. 2000 Sep 15; 51(4):761-70.
[J Biomed Mater Res. 2000]J Natl Cancer Inst. 1964 Jul; 33():15-26.
[J Natl Cancer Inst. 1964]Eur Cell Mater. 2005 Apr 26; 9():39-49.
[Eur Cell Mater. 2005]Nature. 2000 Jan 13; 403(6766):173-5.
[Nature. 2000]Biomaterials. 2005 Feb; 26(5):563-70.
[Biomaterials. 2005]IEEE Trans Nanobioscience. 2004 Jun; 3(2):90-5.
[IEEE Trans Nanobioscience. 2004]Biomed Mater Eng. 2004; 14(4):545-56.
[Biomed Mater Eng. 2004]Clin Oral Implants Res. 2001 Oct; 12(5):515-25.
[Clin Oral Implants Res. 2001]Clin Oral Implants Res. 2000 Apr; 11(2):116-28.
[Clin Oral Implants Res. 2000]Biomaterials. 2000 Apr; 21(7):667-81.
[Biomaterials. 2000]J Biomed Mater Res. 2000 Feb; 49(2):155-66.
[J Biomed Mater Res. 2000]Biomaterials. 2004 Feb; 25(3):403-13.
[Biomaterials. 2004]J Oral Rehabil. 2006 Dec; 33(12):898-911.
[J Oral Rehabil. 2006]Biomaterials. 2005 Feb; 26(4):383-92.
[Biomaterials. 2005]J Biomed Mater Res A. 2006 Oct; 79(1):166-75.
[J Biomed Mater Res A. 2006]Biomaterials. 2004 Feb; 25(4):625-31.
[Biomaterials. 2004]Acta Biomater. 2005 Mar; 1(2):211-22.
[Acta Biomater. 2005]J Biomed Mater Res. 2000 Mar 5; 49(3):362-8.
[J Biomed Mater Res. 2000]Biomaterials. 2004 Aug; 25(17):3351-8.
[Biomaterials. 2004]J Biomed Mater Res A. 2006 Jul; 78(1):97-103.
[J Biomed Mater Res A. 2006]Clin Oral Implants Res. 2007 Apr; 18(2):153-60.
[Clin Oral Implants Res. 2007]Clin Oral Implants Res. 2001 Oct; 12(5):515-25.
[Clin Oral Implants Res. 2001]Clin Oral Implants Res. 2000 Apr; 11(2):116-28.
[Clin Oral Implants Res. 2000]Clin Implant Dent Relat Res. 2004; 6(4):230-8.
[Clin Implant Dent Relat Res. 2004]Trends Biotechnol. 2001 Mar; 19(3):97-101.
[Trends Biotechnol. 2001]Biochem Soc Symp. 1999; 65():15-26.
[Biochem Soc Symp. 1999]Biomaterials. 2003 Mar; 24(7):1147-58.
[Biomaterials. 2003]Biomaterials. 2003 Nov; 24(26):4799-818.
[Biomaterials. 2003]J Biomed Mater Res A. 2006 Aug; 78(2):222-35.
[J Biomed Mater Res A. 2006]Biomaterials. 2006 May; 27(14):2829-44.
[Biomaterials. 2006]Clin Orthop Relat Res. 2002 Jan; (394):278-89.
[Clin Orthop Relat Res. 2002]J Biomed Mater Res. 2001 Dec 15; 57(4):485-96.
[J Biomed Mater Res. 2001]Calcif Tissue Int. 2006 May; 78(5):314-25.
[Calcif Tissue Int. 2006]J Mater Sci Mater Med. 1999 Dec; 10(12):815-9.
[J Mater Sci Mater Med. 1999]J Biomed Mater Res A. 2005 Jan 1; 72(1):36-46.
[J Biomed Mater Res A. 2005]Clin Oral Implants Res. 2006 Jun; 17(3):251-7.
[Clin Oral Implants Res. 2006]Biomaterials. 2006 Oct; 27(30):5199-211.
[Biomaterials. 2006]Eur Cell Mater. 2006 Jan 19; 11():8-15.
[Eur Cell Mater. 2006]J Biomed Mater Res A. 2005 May 1; 73(2):223-33.
[J Biomed Mater Res A. 2005]Biomaterials. 2006 Jun; 27(16):3064-74.
[Biomaterials. 2006]J Biomed Mater Res. 2000 Jun 5; 50(3):353-64.
[J Biomed Mater Res. 2000]Biomaterials. 2004 Feb; 25(3):403-13.
[Biomaterials. 2004]J Biomed Mater Res A. 2007 Sep 1; 82(3):658-68.
[J Biomed Mater Res A. 2007]J Mater Sci Mater Med. 2005 May; 16(5):379-85.
[J Mater Sci Mater Med. 2005]Biomaterials. 2006 Jun; 27(16):3064-74.
[Biomaterials. 2006]Biomaterials. 2005 May; 26(14):1977-86.
[Biomaterials. 2005]Ann Biomed Eng. 2005 Oct; 33(10):1319-32.
[Ann Biomed Eng. 2005]Clin Oral Implants Res. 2007 Jun; 18(3):345-53.
[Clin Oral Implants Res. 2007]Acta Orthop Scand. 2004 Jun; 75(3):295-302.
[Acta Orthop Scand. 2004]J Mater Sci Mater Med. 2004 Apr; 15(4):321-5.
[J Mater Sci Mater Med. 2004]Acta Biomater. 2005 Mar; 1(2):223-34.
[Acta Biomater. 2005]J Biomed Mater Res A. 2004 Aug 1; 70(2):194-205.
[J Biomed Mater Res A. 2004]Proc Natl Acad Sci U S A. 2002 Aug 6; 99(16):10287-92.
[Proc Natl Acad Sci U S A. 2002]J Biomed Mater Res. 1999 Feb; 44(2):176-90.
[J Biomed Mater Res. 1999]J Appl Biomater. 1995 Summer; 6(2):109-16.
[J Appl Biomater. 1995]Biomaterials. 2004 Mar-Apr; 25(7-8):1233-8.
[Biomaterials. 2004]J Orthop Res. 2004 Nov; 22(6):1231-6.
[J Orthop Res. 2004]Biomaterials. 1995 Mar; 16(4):287-95.
[Biomaterials. 1995]Dent Mater J. 2003 Dec; 22(4):507-20.
[Dent Mater J. 2003]Biomaterials. 2005 May; 26(15):2371-9.
[Biomaterials. 2005]Biomed Tech (Berl). 2002 May; 47(5):111-6.
[Biomed Tech (Berl). 2002]J Orthop Res. 2004 Mar; 22(2):229-36.
[J Orthop Res. 2004]J Bone Miner Res. 2003 Sep; 18(9):1573-83.
[J Bone Miner Res. 2003]Biomaterials. 2005 Apr; 26(11):1271-86.
[Biomaterials. 2005]Biomaterials. 1998 Dec; 19(24):2297-302.
[Biomaterials. 1998]Clin Orthop Relat Res. 1997 Sep; (342):205-17.
[Clin Orthop Relat Res. 1997]Arch Orthop Trauma Surg. 1998; 118(1-2):89-91.
[Arch Orthop Trauma Surg. 1998]Biomaterials. 2004 Aug; 25(18):4037-45.
[Biomaterials. 2004]Toxicol Lett. 2006 Feb 20; 161(2):135-42.
[Toxicol Lett. 2006]Small. 2006 Dec; 2(12):1406-11.
[Small. 2006]Crit Rev Ther Drug Carrier Syst. 2006; 23(4):259-318.
[Crit Rev Ther Drug Carrier Syst. 2006]J Bone Miner Res. 1995 Sep; 10(9):1417-27.
[J Bone Miner Res. 1995]Clin Orthop Relat Res. 1997 Sep; (342):205-17.
[Clin Orthop Relat Res. 1997]Biomaterials. 2003 Sep; 24(21):3655-61.
[Biomaterials. 2003]J Biomed Mater Res. 1999 Jun 15; 45(4):311-21.
[J Biomed Mater Res. 1999]J Bone Miner Res. 1998 May; 13(5):793-802.
[J Bone Miner Res. 1998]Acta Biochim Pol. 2003; 50(4):1019-38.
[Acta Biochim Pol. 2003]Calcif Tissue Int. 2003 Apr; 72(4):505-12.
[Calcif Tissue Int. 2003]Ann Med. 2003; 35(8):564-77.
[Ann Med. 2003]Curr Opin Cell Biol. 1998 Apr; 10(2):220-31.
[Curr Opin Cell Biol. 1998]J Biomed Mater Res. 2002; 63(3):252-61.
[J Biomed Mater Res. 2002]Biomol Eng. 2002 Aug; 19(2-6):79-83.
[Biomol Eng. 2002]Biomaterials. 2000 Apr; 21(7):667-81.
[Biomaterials. 2000]Implant Dent. 2001; 10(2):132-8.
[Implant Dent. 2001]